<?xml version="1.0" encoding="UTF-8"?>
<ref id="B121-pharmaceuticals-13-00283">
 <label>121.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yang</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Gao</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Jia</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>SIRT1 is downregulated in gastric cancer and leads to G1-phase arrest via NF-kB/Cyclin D1 signaling</article-title>
  <source>Mol. Cancer Res.</source>
  <year>2013</year>
  <volume>11</volume>
  <fpage>1497</fpage>
  <lpage>1507</lpage>
  <pub-id pub-id-type="doi">10.1158/1541-7786.MCR-13-0214</pub-id>
  <?supplied-pmid 24107295?>
  <pub-id pub-id-type="pmid">24107295</pub-id>
 </element-citation>
</ref>
